Amneal Pharmaceuticals, Inc. Class A Common Stock vs. Eli Lilly & Co.
AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
$19.45 -2.51%
VS LLYEli Lilly & Co.
$1437.29 +0.35%
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| AMRX | LLY | |
|---|---|---|
| Market Cap | $6.95 billion | $1.28 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| AMRX | LLY | |
|---|---|---|
| Dividend Yield | — | 0.48% |
AMRX and LLY split the dividend factors evenly.
Risk & Sentiment
| AMRX | LLY | |
|---|---|---|
| Short Interest | 2.39% | 1.29% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMRX overview, AMRX financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.